Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Amn Healthcare Services (AMN) Accumulated Depreciation & Amortization (2016 - 2025)

Amn Healthcare Services' Accumulated Depreciation & Amortization history spans 16 years, with the latest figure at $156.6 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 9.89% year-over-year to $156.6 million; the TTM value through Dec 2025 reached $156.6 million, down 9.89%, while the annual FY2025 figure was $156.6 million, 9.89% down from the prior year.
  • Accumulated Depreciation & Amortization reached $156.6 million in Q4 2025 per AMN's latest filing, up from $119.4 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $173.8 million in Q4 2024 to a low of $23.7 million in Q1 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $90.7 million, with a median of $84.5 million recorded in 2024.
  • Peak YoY movement for Accumulated Depreciation & Amortization: soared 32.81% in 2022, then decreased 10.66% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $103.7 million in 2021, then surged by 32.22% to $137.1 million in 2022, then rose by 17.37% to $160.9 million in 2023, then increased by 7.99% to $173.8 million in 2024, then decreased by 9.89% to $156.6 million in 2025.
  • Per Business Quant, the three most recent readings for AMN's Accumulated Depreciation & Amortization are $156.6 million (Q4 2025), $119.4 million (Q3 2025), and $79.7 million (Q2 2025).